Updated Gout Guidelines: Pearls for Practice

PROGRAM DESCRIPTION At the present time, gout is treated suboptimally. Poor disease control with recurrent flares and frequent hospitalizations are common. In addition, only 30% of patients who are candidates ...

PROGRAM DESCRIPTION
At the present time, gout is treated suboptimally. Poor disease control with recurrent flares and frequent hospitalizations are common. In addition, only 30% of patients who are candidates for urate-lowering therapy actually receive it. Updated guidelines recently published by the American College of Physicians (ACP) directly contradict the “treat-to-target” focus on controlling serum uric acid levels that is recommended by the American College of Rheumatology (ACR) and the European League against Rheumatism (EULAR). As a result, clinicians may be uncertain as to why and how to treat underlying hyperuricemia in patients with gout.In this educational activity, 2 gout clinical experts review key pearls from evidence-based guidelines for gout management, including those from the ACP, ACR, and EULAR. Key differences among the various recommendations relative to the long-term management of hyperuricemia will be discussed in detail, and the implications for clinical practice will be reviewed.

EDUCATIONAL OBJECTIVES
After completing the activity, the participant should be better able to:Describe the rationale for addressing underlying hyperuricemia in patients with goutReview key differences in evidence-based guidelines for gout management disseminated by leading national medical organizations

---

Write the first review

Resource tags